Stock Analysis on Net

Zoetis Inc. (NYSE:ZTS)

This company has been moved to the archive! The financial data has not been updated since May 5, 2022.

Analysis of Liquidity Ratios

Microsoft Excel

Liquidity Ratios (Summary)

Zoetis Inc., liquidity ratios

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Current ratio 3.86 3.05 2.63 3.60 3.85
Quick ratio 2.57 2.13 1.67 2.24 2.34
Cash ratio 1.94 1.66 1.07 1.39 1.43

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Zoetis Inc. current ratio improved from 2019 to 2020 and from 2020 to 2021.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Zoetis Inc. quick ratio improved from 2019 to 2020 and from 2020 to 2021.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Zoetis Inc. cash ratio improved from 2019 to 2020 and from 2020 to 2021.

Current Ratio

Zoetis Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Current assets 6,930 6,611 4,748 4,399 4,217
Current liabilities 1,797 2,170 1,806 1,223 1,094
Liquidity Ratio
Current ratio1 3.86 3.05 2.63 3.60 3.85
Benchmarks
Current Ratio, Competitors2
AbbVie Inc. 0.79 0.84 3.18
Amgen Inc. 1.59 1.81 1.44
Bristol-Myers Squibb Co. 1.52 1.58 1.60
Eli Lilly & Co. 1.23 1.40 1.16
Gilead Sciences Inc. 1.27 1.40 3.10
Johnson & Johnson 1.35 1.21 1.26
Merck & Co. Inc. 1.27 1.02 1.24
Pfizer Inc. 1.40 1.35 0.88
Regeneron Pharmaceuticals Inc. 3.56 3.63 3.67
Thermo Fisher Scientific Inc. 1.50 2.13 1.92
Vertex Pharmaceuticals Inc. 4.46 4.33 3.61
Current Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 1.36 1.36 1.56
Current Ratio, Industry
Health Care 1.22 1.22 1.34

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Current ratio = Current assets ÷ Current liabilities
= 6,930 ÷ 1,797 = 3.86

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Zoetis Inc. current ratio improved from 2019 to 2020 and from 2020 to 2021.

Quick Ratio

Zoetis Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Cash and cash equivalents 3,485 3,604 1,934 1,602 1,564
Short-term investments 99
Accounts receivable, less allowance for doubtful accounts 1,133 1,013 1,086 1,036 998
Total quick assets 4,618 4,617 3,020 2,737 2,562
 
Current liabilities 1,797 2,170 1,806 1,223 1,094
Liquidity Ratio
Quick ratio1 2.57 2.13 1.67 2.24 2.34
Benchmarks
Quick Ratio, Competitors2
AbbVie Inc. 0.56 0.60 2.91
Amgen Inc. 1.06 1.30 1.01
Bristol-Myers Squibb Co. 1.20 1.28 1.26
Eli Lilly & Co. 0.80 0.85 0.68
Gilead Sciences Inc. 0.95 1.08 2.86
Johnson & Johnson 1.04 0.91 0.94
Merck & Co. Inc. 0.73 0.58 0.78
Pfizer Inc. 1.00 0.78 0.50
Regeneron Pharmaceuticals Inc. 2.98 2.86 2.81
Thermo Fisher Scientific Inc. 1.00 1.63 1.19
Vertex Pharmaceuticals Inc. 4.04 4.02 3.33
Quick Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.98 0.96 1.18
Quick Ratio, Industry
Health Care 0.90 0.91 1.01

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 4,618 ÷ 1,797 = 2.57

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Zoetis Inc. quick ratio improved from 2019 to 2020 and from 2020 to 2021.

Cash Ratio

Zoetis Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Cash and cash equivalents 3,485 3,604 1,934 1,602 1,564
Short-term investments 99
Total cash assets 3,485 3,604 1,934 1,701 1,564
 
Current liabilities 1,797 2,170 1,806 1,223 1,094
Liquidity Ratio
Cash ratio1 1.94 1.66 1.07 1.39 1.43
Benchmarks
Cash Ratio, Competitors2
AbbVie Inc. 0.28 0.30 2.56
Amgen Inc. 0.66 0.91 0.69
Bristol-Myers Squibb Co. 0.78 0.83 0.84
Eli Lilly & Co. 0.26 0.29 0.21
Gilead Sciences Inc. 0.56 0.65 2.50
Johnson & Johnson 0.70 0.59 0.54
Merck & Co. Inc. 0.34 0.30 0.47
Pfizer Inc. 0.73 0.47 0.26
Regeneron Pharmaceuticals Inc. 1.45 1.33 1.53
Thermo Fisher Scientific Inc. 0.33 1.00 0.39
Vertex Pharmaceuticals Inc. 3.51 3.55 2.85
Cash Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.59 0.58 0.81
Cash Ratio, Industry
Health Care 0.52 0.54 0.64

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 2021 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 3,485 ÷ 1,797 = 1.94

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Zoetis Inc. cash ratio improved from 2019 to 2020 and from 2020 to 2021.